{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:41:38Z","timestamp":1791632498200,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.gastrohep.2017.12.009","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T13:58:34Z","timestamp":1517925514000},"page":"272-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Actualizaci\u00f3n en el manejo de la infecci\u00f3n por Helicobacter pylori. Documento de posicionamiento de la Societat Catalana de Digestologia"],"prefix":"10.1016","volume":"41","author":[{"given":"Jordi","family":"S\u00e1nchez Delgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Garc\u00eda-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ll\u00facia","family":"Tit\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Planella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emili","family":"Gen\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Sal\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Mart\u00ednez-Cerezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Molina-Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2017.12.009_bib0215","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0220","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1093\/jnci\/95.7.E3","article-title":"Bacterial infections as a cause of cancer","volume":"95","author":"Correa","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0225","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jcp.47.5.436","article-title":"Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas","volume":"47","author":"Eidt","year":"1994","journal-title":"J Clin Pathol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0889-8553(21)00271-5","article-title":"Treatment strategies for Helicobacter pylori infection","volume":"22","author":"Marshall","year":"1993","journal-title":"Gastroenterol Clin North Am."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0235","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection--The Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0240","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(11)60825-8","article-title":"14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: A randomised trial","volume":"378","author":"Greenberg","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0245","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-The Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0260","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.gastrohep.2016.05.003","article-title":"[IV Spanish Consensus Conference on Helicobacter pylori infection treatment] Spanish","volume":"39","author":"Gisbert","year":"2016","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0265","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.gastrohep.2013.01.011","article-title":"III Conferencia Espa\u00f1ola de Consenso sobre la infecci\u00f3n por Helicobacter pylori","volume":"36","author":"Gisbert","year":"2013","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0270","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: Treatment of Helicobacter pylori infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0275","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-Functional GI disorders: Disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0280","doi-asserted-by":"crossref","first-page":"985249","DOI":"10.1155\/2015\/985249","article-title":"Helicobacter pylori infection in gastroesophageal reflux disease in the Asian countries","volume":"2015","author":"Hong","year":"2015","journal-title":"Gastroenterol Res Pract."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0285","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bmj.326.7392.737","article-title":"Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: Systematic review","volume":"326","author":"Raghunath","year":"2003","journal-title":"BMJ."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2017.12.009_bib0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/hel.12337","article-title":"Helicobacter pylori and non-malignant upper gastrointestinal diseases","volume":"21","author":"Vasapolli","year":"2016","journal-title":"Helicobacter."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0295","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/ajg.2009.172","article-title":"H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole","volume":"104","author":"Yang","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0300","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/apt.14424","article-title":"Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - A prospective study for up to 10 years","volume":"47","author":"Hwang","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0305","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2036.2004.01898.x","article-title":"Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer","volume":"19","author":"Gisbert","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0310","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ajg.2012.132","article-title":"Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding","volume":"107","author":"Gisbert","year":"2012","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0315","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: A systematic review and meta-analysis","volume":"145","author":"Holster","year":"2013","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0320","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0325","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(97)04523-6","article-title":"Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers","volume":"350","author":"Chan","year":"1997","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0330","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/gut.51.3.329","article-title":"Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: A randomised, double blind, placebo controlled, clinical trial","volume":"51","author":"Labenz","year":"2002","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0335","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1365-2036.2003.01528.x","article-title":"Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: A double-blind, placebo-controlled trial","volume":"17","author":"Lai","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0340","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1523-5378.2007.00543.x","article-title":"Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: Double-blind, randomized, placebo-controlled trial","volume":"12","author":"De Leest","year":"2007","journal-title":"Helicobacter."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","article-title":"Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: A randomised trial","volume":"359","author":"Chan","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0350","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0355","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1053\/j.gastro.2012.12.038","article-title":"Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users","volume":"144","author":"Chan","year":"2013","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0360","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2010.04415.x","article-title":"Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin","volume":"32","author":"Fletcher","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0365","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ajg.2015.98","article-title":"Peptic ulcer bleeding risk. The role of Helicobacter pylori infection in NSAID\/low-dose aspirin users","volume":"110","author":"Sostres","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0370","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.3748\/wjg.v21.i40.11221","article-title":"Diagnosis of Helicobacter pylori infection: Current options and developments","volume":"21","author":"Wang","year":"2015","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0375","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1086\/598198","article-title":"Accuracy of diagnostic tests for Helicobacter pylori: A reappraisal","volume":"48","author":"Calvet","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0380","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1086\/649860","article-title":"Comparative accuracy of 3 monoclonal stool tests for diagnosis of Helicobacter pylori infection among patients with dyspepsia","volume":"50","author":"Calvet","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0385","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clinbiochem.2016.01.015","article-title":"Diagnostic accuracy of three monoclonal stool tests in a large series of untreated Helicobacter pylori infected patients","volume":"49","author":"Lario","year":"2016","journal-title":"Clin Biochem."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0390","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1523-5378.2010.00757.x","article-title":"Accuracy of monoclonal stool tests for determining cure of Helicobacter pylori infection after treatment","volume":"15","author":"Calvet","year":"2010","journal-title":"Helicobacter."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0395","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1572-0241.2006.00668.x","article-title":"Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: A systematic review and meta-analysis","volume":"101","author":"Gisbert","year":"2006","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0400","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jim-2015-000004","article-title":"Good diagnostic accuracy of a chemiluminescent immunoassay in stool samples for diagnosis of Helicobacter pylori infection in patients with dyspepsia","volume":"64","author":"Ram\u00edrez-L\u00e1zaro","year":"2016","journal-title":"J Investig Med."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0405","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1365-2036.2001.00984.x","article-title":"Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment","volume":"15","author":"Calvet","year":"2001","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0410","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","article-title":"Meta-analysis: High-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication","volume":"28","author":"Villoria","year":"2008","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0415","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/apt.13128","article-title":"Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments","volume":"41","author":"Gisbert","year":"2015","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2017.12.009_bib0420","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","article-title":"Role of bismuth in improving Helicobacter pylori eradication with triple therapy","volume":"65","author":"Dore","year":"2016","journal-title":"Gut."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570518300104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570518300104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:31:08Z","timestamp":1719793868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570518300104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0210570518300104"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2017.12.009","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualizaci\u00f3n en el manejo de la infecci\u00f3n por Helicobacter pylori. Documento de posicionamiento de la Societat Catalana de Digestologia","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}